uniQure-UniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates

UniQure (QURE) came out with a quarterly loss of $0.82 per share versus the Zacks Consensus Estimate of a loss of$ 1.07. This compares to loss of $1.36 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 23.36%. A quarter ago, it was expected that this human gene therapy company would post a loss of$ 0.44 per share when it actually produced a loss of $1.50, delivering a surprise of -240.91%.Over the last four quarters, the company ...